U.S. markets open in 44 minutes
  • S&P Futures

    3,931.50
    -13.50 (-0.34%)
     
  • Dow Futures

    33,583.00
    -50.00 (-0.15%)
     
  • Nasdaq Futures

    11,493.00
    -73.00 (-0.63%)
     
  • Russell 2000 Futures

    1,812.10
    -2.00 (-0.11%)
     
  • Crude Oil

    75.20
    +0.95 (+1.28%)
     
  • Gold

    1,790.10
    +7.70 (+0.43%)
     
  • Silver

    22.67
    +0.34 (+1.50%)
     
  • EUR/USD

    1.0532
    +0.0063 (+0.60%)
     
  • 10-Yr Bond

    3.5290
    +0.0160 (+0.46%)
     
  • Vix

    22.75
    +2.00 (+9.64%)
     
  • GBP/USD

    1.2204
    +0.0071 (+0.59%)
     
  • USD/JPY

    136.7600
    -0.2000 (-0.15%)
     
  • BTC-USD

    16,855.42
    -166.66 (-0.98%)
     
  • CMC Crypto 200

    395.65
    -6.15 (-1.53%)
     
  • FTSE 100

    7,530.56
    +9.17 (+0.12%)
     
  • Nikkei 225

    27,686.40
    -199.47 (-0.72%)
     

Highly Rated Amylyx Pharma Skids After Hard-Fought FDA Approval For ALS Drug

Highly Rated Amylyx Pharma Skids After Hard-Fought FDA Approval For ALS Drug

The Food and Drug Administration granted Amylyx Pharmaceuticals a hard-won approval in ALS treatment, but AMLX stock sank Friday.